Russell Investments Group
HLVX

Russell Investments Group’s HilleVax HLVX Stock Holding History

Russell Investments Group’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23,939
Closed -$47.5K – 4183
2025
Q2 		$47.5K Buy
23,939
+6,601
+38% +$12.1K ﹤0.01% 2993
2025
Q1 		$25.1K Sell
17,338
-20,898
-55% -$38.6K ﹤0.01% 3059
2024
Q4 		$79.1K Buy
38,236
+29,303
+328% +$55K ﹤0.01% 2733
2024
Q3 		$15.7K Buy
8,933
+8,199
+1,117% +$21K ﹤0.01% 3005
2024
Q2 		$10.6K Buy
734
+675
+1,144% +$9.27K ﹤0.01% 3061
2024
Q1 		$981 Buy
59
+41
+228% +$656 ﹤0.01% 3135
2023
Q4 		$289 Hold
18
– – ﹤0.01% 3159
2023
Q3 		$242 Sell
18
-1,554
-99% -$21.9K ﹤0.01% 3467
2023
Q2 		$27K Hold
1,572
– – ﹤0.01% 2803
2023
Q1 		$26K Buy
+1,572
New +$25.1K ﹤0.01% 2785

Russell Investments Group's HLVX Position: Q3 2025 in Review

Russell Investments Group sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 23,939 shares — an estimated $47.5K sold.

Russell Investments Group first reported a position in HLVX in Q1 2023 and held it in 10 quarters. The position peaked at $79.1K in Q4 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Russell Investments Group reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Russell Investments Group sold 23,939 HilleVax shares in Q3 2025, an estimated $47.5K.
  • Russell Investments Group first reported a position in HilleVax in Q1 2023 and held it in 10 quarters.
  • Russell Investments Group's HilleVax position peaked at $79.1K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Russell Investments Group's 13F filing for Q3 2025, filed 13 Nov 2025.